10x Genomics Stock Forecast

Buy or Hold candidate since May 20, 2026 Gain 53.25%

The 10x Genomics, Inc. stock price gained 2.85% on the last trading day (Friday, 26th Jun 2026), rising from $35.73 to $36.75. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 7.17% from a day low at $34.57 to a day high of $37.05. The price has risen in 6 of the last 10 days and is up by 26.51% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 6 million more shares were traded than the day before. In total, 9 million shares were bought and sold for approximately $340.59 million.

The stock has broken the very wide and strong rising the short-term trend up and an even stronger rate of rising is indicated. For any reaction back there will now be support on the roof on the current trend broken at $36.00, a level that may pose a second chance to hit a runner. According to fan-theory $43.53 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

TXG Signals & Forecast

The 10x Genomics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $34.11 and $27.95. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, April 29, 2026, and so far it has risen 81.93%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for 10x Genomics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $32.94 and $32.22. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, 10x Genomics, Inc. finds support just below today's level at $32.94. If this is broken, then the next support from accumulated volume will be at $32.22 and $32.13.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.48 between high and low, or 7.17%. For the last week, the stock has had daily average volatility of 8.04%.

Our recommended stop-loss: $35.39 (-3.70%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 40 days ago.)

Trading Expectations (TXG) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect 10x Genomics, Inc. to open at $36.12, and during the day (based on 14 day Average True Range), to move between $35.55 and $37.95, which gives a possible trading interval of +/-$2.39 (+/-6.72%) up or down from last closing price. If 10x Genomics, Inc. takes out the full calculated possible swing range there will be an estimated 6.72% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $32.94, some $3.81 (10.37%) from the current price of $36.75, our system finds the risk reward attractive.

Is 10x Genomics, Inc. stock A Buy?

10x Genomics, Inc. holds several positive signals and has broken the strong rising trend up. As the stock is also in great technical shape we, therefore, consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

Current score: 8.000 Strong Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 29, 2026 - $36.12 ( 1.71%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk